PCI Biotech announces that CEO, Dr Per Walday has resigned to assume a new position. Dr Walday has a notice period of six months, and he will step down from his position by the end of September 2022, or earlier. The Board of Directors will initiate a succession process.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.648 NOK | +0.12% | +3.91% | -21.34% |
1st Jan change | Capi. | |
---|---|---|
-21.34% | 5.64M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- PCIB Stock
- News PCI Biotech Holding ASA
- PCI Biotech Holding ASA Announces Resignation on Per Walday as Chief Executive Officer